Neurology

Nxera Pharma Webinar Presentation for Q2 FY2024 Financial ResultsNxera Pharma Webinar Presentation for Q2 FY2024 Financial Results

Nxera Pharma Webinar Presentation for Q2 FY2024 Financial Results

Tokyo, Japan and Cambridge, UK, 9 July 2024 - Nxera Pharma Co. Ltd (“Nxera”; TSE 4565) will announce its earnings…

11 months ago
uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s DiseaseuniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease

uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease

~ Achieved statistically significant, dose-dependent, and durable evidence of potential therapeutic benefit; Patients receiving high-dose AMT-130 showed 80% slowing of…

11 months ago
Paragon Genomics Partners with Biosecure ID to Expand Access to CleanPlex® Technology in the UK and IrelandParagon Genomics Partners with Biosecure ID to Expand Access to CleanPlex® Technology in the UK and Ireland

Paragon Genomics Partners with Biosecure ID to Expand Access to CleanPlex® Technology in the UK and Ireland

--Follows A Half Dozen New Distributor Agreements Around the Globe for Paragon Genomics’ Unique CleanPlex® NGS Target Enrichment Technology--FREMONT, Calif.,…

11 months ago
Just – Evotec Biologics Expands Tech Partnership for Biosimilars with SandozJust – Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz

Just – Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz

Just - Evotec Biologics expands partnership with Sandoz for development and commercial manufacturing of biosimilarsAdditional biosimilars potentially to be added…

11 months ago
Methodist Le Bonheur Healthcare named among Best in Cancer Care by Money magazineMethodist Le Bonheur Healthcare named among Best in Cancer Care by Money magazine

Methodist Le Bonheur Healthcare named among Best in Cancer Care by Money magazine

MEMPHIS, Tenn., July 5, 2024 /PRNewswire/ -- Methodist Le Bonheur Healthcare announced its four Memphis-based adult hospitals placed among Money magazine's top…

11 months ago
Assure Announces Reverse Stock Split to support Continued Listing on NASDAQAssure Announces Reverse Stock Split to support Continued Listing on NASDAQ

Assure Announces Reverse Stock Split to support Continued Listing on NASDAQ

DENVER, July 03, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative…

12 months ago
Pusan National University Researchers Assess the Impact of Repeated Item Development Faculty Training on Item Difficulty PredictionPusan National University Researchers Assess the Impact of Repeated Item Development Faculty Training on Item Difficulty Prediction

Pusan National University Researchers Assess the Impact of Repeated Item Development Faculty Training on Item Difficulty Prediction

Repeated item development training helps faculty better predict and adjust item difficulty in medical education assessments BUSAN, South Korea, July…

12 months ago
SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PNSpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN

SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN

STAMFORD, Conn., July 01, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe…

12 months ago
Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven yearsGrifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years

Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years

Biotest, a Grifols Group company, is expected to launch its recently FDA-approved intravenous immunoglobulin in the U.S. in first quarter…

12 months ago
Orchard Therapeutics Celebrates Global Progress toward Advancing Newborn Screening for MLD on International Neonatal Screening DayOrchard Therapeutics Celebrates Global Progress toward Advancing Newborn Screening for MLD on International Neonatal Screening Day

Orchard Therapeutics Celebrates Global Progress toward Advancing Newborn Screening for MLD on International Neonatal Screening Day

A nomination to add MLD to the U.S. Recommended Uniform Screening Panel has been submitted by a multi-disciplinary expert working…

12 months ago